140 related articles for article (PubMed ID: 9279834)
21. [Reasons for the change in HRT therapy from the perspective of women. Results of the German Cohort Study on Women's Health].
Thiel C; Heinemann LA; Assmann A;
Zentralbl Gynakol; 2001 Jul; 123(7):390-8. PubMed ID: 11534299
[TBL] [Abstract][Full Text] [Related]
22. [Compliance with hormone replacement therapy].
Rozenberg S; Vandromme J; Kroll M; Twagirayezu P; Vyankandondera J
Rev Med Brux; 1995; 16(4):295-8. PubMed ID: 7481246
[TBL] [Abstract][Full Text] [Related]
23. Weighing the cons and pros: women's reasons for discontinuing hormone replacement therapy.
Reece SM
Health Care Women Int; 2002 Jan; 23(1):19-32. PubMed ID: 11822557
[TBL] [Abstract][Full Text] [Related]
24. Patterns and correlates of hormone replacement therapy use among middle-aged Australian women.
France K; Schofield MJ; Lee C
Womens Health; 1997; 3(2):121-38. PubMed ID: 9332154
[TBL] [Abstract][Full Text] [Related]
25. [Hormone replacement therapy--women's expectations and fears].
Schultz-Zehden B
Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):180-8. PubMed ID: 10802891
[TBL] [Abstract][Full Text] [Related]
26. Menopause in Croatia. Socio-demographic characteristics, women's attitudes and source of information, compliance with HRT.
Fistonic I; Srecko C; Marina F; Ivan S
Maturitas; 2004 Feb; 47(2):91-8. PubMed ID: 14757267
[TBL] [Abstract][Full Text] [Related]
27. Has the impact of hormone replacement therapy on health-related quality of life been undervalued?
Tosteson AN; Gabriel SE; Kneeland TS; Moncur MM; Manganiello PD; Schiff I; Ettinger B; Melton LJ
J Womens Health Gend Based Med; 2000 Mar; 9(2):119-30. PubMed ID: 10746515
[TBL] [Abstract][Full Text] [Related]
28. Women's control and choice regarding HRT.
Griffiths F
Soc Sci Med; 1999 Aug; 49(4):469-81. PubMed ID: 10414807
[TBL] [Abstract][Full Text] [Related]
29. Spanish post-menopausal women's viewpoints on hormone therapy.
Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
[TBL] [Abstract][Full Text] [Related]
30. Determinants of Hormone Replacement Therapy Knowledge and Current Hormone Replacement Therapy Use.
Doamekpor LA; Head SK; South E; Louie C; Zakharkin S; Vasisht K; Bersoff-Matcha S
J Womens Health (Larchmt); 2023 Mar; 32(3):283-292. PubMed ID: 36459626
[No Abstract] [Full Text] [Related]
31. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
Ushiroyama T; Ikeda A; Sakuma K; Ueki M
J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
[TBL] [Abstract][Full Text] [Related]
32. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
[TBL] [Abstract][Full Text] [Related]
33. Women's decisions about whether or not to take hormone replacement therapy: influence of social and medical factors.
Griffiths F
Br J Gen Pract; 1995 Sep; 45(398):477-80. PubMed ID: 7546871
[TBL] [Abstract][Full Text] [Related]
34. Influences of hormone replacement therapy on postmenopausal women's health perceptions.
Blümel JE; Castelo-Branco C; Kerrigan N; Cancelo MJ; Blümel B; Haya J; Flores M; Carvajal MC; Sarrá S
Menopause; 2003; 10(3):235-40. PubMed ID: 12792296
[TBL] [Abstract][Full Text] [Related]
35. Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine.
Fishman JR; Flatt MA; Settersten RA
Soc Sci Med; 2015 May; 132():79-87. PubMed ID: 25795991
[TBL] [Abstract][Full Text] [Related]
36. Use, intentions, and beliefs about hormone replacement therapy in women with and without diabetes.
Huston SA; Kirking DM; Shimp LA
Maturitas; 2006 Aug; 55(1):58-68. PubMed ID: 16504429
[TBL] [Abstract][Full Text] [Related]
37. Compliance to hormone replacement therapy.
Rozenberg S; Vandromme J; Kroll M; Pastijn A; Liebens F
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():23-32. PubMed ID: 7581586
[TBL] [Abstract][Full Text] [Related]
38. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
39. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
Grimes DA; Lobo RA
Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
[TBL] [Abstract][Full Text] [Related]
40. Health beliefs and women's use of hormone replacement therapy.
McGinley AM
Holist Nurs Pract; 2004; 18(1):18-25. PubMed ID: 14765688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
